Cargando…

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson’s disease patients

Loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) and a profound reduction of striatal dopamine are two hallmarks of Parkinson’s disease (PD). However, it’s unclear whether degeneration starts at the neuronal soma or the striatal presynaptic terminals, and how microstructural...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Aguirre, M., Matarazzo, M., Blesa, J., Monje, M. H. G., Rodríguez-Rojas, R., Sánchez-Ferro, A., Obeso, J. A., Pineda-Pardo, J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584921/ https://www.ncbi.nlm.nih.gov/pubmed/37852988 http://dx.doi.org/10.1038/s41531-023-00586-x

Ejemplares similares

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2011)

Functional connectivity of the cortico-subcortical sensorimotor loop is modulated by the severity of nigrostriatal dopaminergic denervation in Parkinson’s Disease
por: Quarantelli, Mario, et al.
Publicado: (2022)

Nigrostriatal Dopaminergic Denervation Does Not Promote Impulsive Choice in the Rat: Implication for Impulse Control Disorders in Parkinson’s Disease
por: Magnard, Robin, et al.
Publicado: (2018)

Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014)

Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
por: Machado, A., et al.
Publicado: (2011)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease
por: Wang, Jing, et al.
Publicado: (2020)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

Inflammatory Animal Model for Parkinson's Disease: The Intranigral Injection of LPS Induced the Inflammatory Process along with the Selective Degeneration of Nigrostriatal Dopaminergic Neurons
por: Machado, A., et al.
Publicado: (2011)

TNF superfamily member APRIL enhances midbrain dopaminergic axon growth and contributes to the nigrostriatal projection in vivo
por: McWilliams, Thomas G., et al.
Publicado: (2017)

Nigrostriatal dopaminergic depletion increases static orofacial allodynia
por: Dieb, Wisam, et al.
Publicado: (2016)

Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic Neurotransmission
por: Qin, Qi, et al.
Publicado: (2016)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Naringin as a beneficial natural product against degeneration of the nigrostriatal dopaminergic projection in the adult brain
por: Kim, Sang Ryong
Publicado: (2017)

Nigrostriatal denervation changes the effect of cannabinoids on subthalamic neuronal activity in rats
por: Morera-Herreras, Teresa, et al.
Publicado: (2010)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
por: Carmichael, Kathleen, et al.
Publicado: (2021)

Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson’s Disease
por: Kolacheva, Anna, et al.
Publicado: (2022)

A Mouse Model of Nigrostriatal Dopaminergic Axonal Degeneration As a Tool for Testing Neuroprotectors
por: Kolacheva, A. A., et al.
Publicado: (2021)

Effects of naringin, a flavanone glycoside in grapefruits and citrus fruits, on the nigrostriatal dopaminergic projection in the adult brain
por: Jung, Un Ju, et al.
Publicado: (2014)

Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys
por: Monje, Mariana H.G., et al.
Publicado: (2019)

Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease
por: Trinh, Ilene, et al.
Publicado: (2023)

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons
por: Aguirre, Pabla, et al.
Publicado: (2015)

Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
por: Harrison, Ian F., et al.
Publicado: (2016)

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson’s disease
por: Cai, Huaibin, et al.
Publicado: (2014)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

A Current Review of Cypermethrin-Induced Neurotoxicity and Nigrostriatal Dopaminergic Neurodegeneration
por: Singh, Anand Kumar, et al.
Publicado: (2012)

Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
por: Jeon, B. S.
Publicado: (1997)

Lesion of the dopaminergic nigrostriatal pathway induces trigeminal dynamic mechanical allodynia
por: Dieb, Wisam, et al.
Publicado: (2014)

Atrazine Causes Autophagy- and Apoptosis-Related Neurodegenerative Effects in Dopaminergic Neurons in the Rat Nigrostriatal Dopaminergic System
por: Song, Xiao-Yao, et al.
Publicado: (2015)

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease
por: Chung, Young Cheul, et al.
Publicado: (2013)

Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease
por: Wi, Rayul, et al.
Publicado: (2020)

Subthalamic nucleus deep brain stimulation induces nigrostriatal dopaminergic plasticity in a stable rat model of Parkinson’s disease
por: Helf, Charlotte, et al.
Publicado: (2023)

In vivo Assessment of the Human Nigrostriatal Dopaminergic System Using Positron Emission Tomography
por: Leenders, K. L.
Publicado: (1992)

Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology
por: Sun, Fanfan, et al.
Publicado: (2021)

Correlation of Dopaminergic Denervation and the Progression of Autonomic Dysfunctions in Different Clinical Subtypes of Parkinson's Disease
por: Jeong, Eun Hye, et al.
Publicado: (2021)

Aldehyde dehydrogenase 1–positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum
por: Sgobio, Carmelo, et al.
Publicado: (2017)

Editorial: Parkinson's disease: cell vulnerability and disease progression
por: Blesa, Javier, et al.
Publicado: (2015)

Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function
por: Ciron, C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_981ho4a03t4cetunip2opfmcrd